News
Balloon pulmonary angioplasty beats riociguat in randomized CTEPH trial
MADRID – Balloon pulmonary angioplasty appears to be a better first-line than riociguat for nonoperable chronic thromboembolic pulmonary...
News
Amoxicillin/clavulanate emerges as best antibiotic for childhood bronchiectasis
MADRID – In children with nonsevere bronchiectasis, amoxicillin/clavulanate should be the first-line antibiotic.
News
Dupilumab shrinks nasal polyps in severe chronic rhinosinusitus
MADRID – In patients with severe chronic rhinosinusitus, dupilumab reduces polyp size and symptoms.
News
Automated ventilation outperformed nurses in post-op cardiac care
MADRID – Automated mechanical ventilation keeps post-op patients in safe breathing zones better than nurses.
News
Azithromycin prevents airway complications of antibody deficiency
MADRID – Low-dose azithromycin reduces airway complications in patients with primary antibody deficiencies.
News
Mesh nebulizer worked faster to control acute asthma
MADRID – Relative to jet nebulizers, mesh devices achieve urgent asthma control in children more quickly.
News
Combined treatments provide control of pseudofolliculitis barbae in women
NEW YORK – Start with microdermabrasion to treat the hypertrophic hair follicles and address keratin plugs.
News
Whitening of skin remains charged topic at Skin of Color meeting
NEW YORK – Dermatologists navigate issues raised by requests for lightening agents from nonwhite patients.
News
Trial confirms as-needed inhalers suffice for mild to moderate asthma
MADRID – Yet another trial supports as-needed inhaled steroids for mild to moderate asthma.
News
One-third of patients with severe asthma are overusing corticosteroids
MADRID – Dutch study suggests up to 90% of asthma patients taking oral steroids could reduce exposure.
News
Central centrifugal cicatricial alopecia called epidemic in skin of color
NEW YORK – The failure to diagnose CCCA early can result in devastating hair loss for black women.
News
Six factors predicted benefit from asthma triple therapy
MADRID – Prespecified analysis of newly published TRIMARIN/TRIGGER trials might guide clinical choices.
News
Multicenter trial backs pirfenidone for unclassifiable interstitial lung disease
MADRID – Pirfenidone inhibits progression of unclassifiable interstitial lung disease in placebo-controlled trial.
News
TKI preserved lung function in patients with fibrosing interstitial disease
MADRID – The trial, called INBUILD, enrolled patients who had progressive lung...
News
Still no standard for HS, but new options increase chance of control
NEW YORK – Increasing options for hidradenitis suppurativa might be particularly relevant to black patients.